Yuki Sakakura

1.1k citations
10 papers · 888 indexed · h-index 8
Topics
Cholesterol and Lipid Metabolism (3 papers)Drug Transport and Resistance Mechanisms (3 papers)Amino Acid Enzymes and Metabolism (2 papers)
Partner nations
JapanUnited States

In The Last Decade

Yuki Sakakura

10 papers receiving 863 citations

Peers

Yuki Sakakura
Comparison fields: 5 of 101
  • Molecular Biology 449
  • Biochemistry 204
  • Pulmonary and Respiratory Medicine 183
  • Cancer Research 151
  • Surgery 117
Replace Maria P. Lambros with:
Maria P. Lambros United States
Wenhong Xu China
Xiaoming Lu China
Kimiko Ishiguro United States
Jerome Garcia United States
Eva Bernhart Austria
Daqing Sun China
Takashi Ono Japan
Isao Kobayashi Japan
Peter J. Bungay United Kingdom
Yuki Sakakura relative to Maria P. Lambros United States Maria P. Lambros's profile →
Citations per field
00.5×4.2×
Maria P. Lambros · 1×
Citations per year

Countries citing papers authored by Yuki Sakakura

Since Specialization
Citations

This map shows the geographic impact of Yuki Sakakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Sakakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Sakakura more than expected).

Fields of papers citing papers by Yuki Sakakura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Sakakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Sakakura. The network helps show where Yuki Sakakura may publish in the future.

Co-authorship network of co-authors of Yuki Sakakura

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Sakakura. A scholar is included among the top collaborators of Yuki Sakakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Sakakura. Yuki Sakakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 38
2 7
3 45
4 346
5 97
6 79
7 30
8 67
9 174
10 5

About Yuki Sakakura

Yuki Sakakura is a scholar working on Biochemistry, Behavioral Neuroscience and Developmental Neuroscience, having authored 10 papers that have together received 888 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Biochemistry (204 citations), Cancer Research (151 citations) and Pharmaceutical Science (42 citations). Yuki Sakakura has collaborated with scholars based in Japan and United States. Frequent co-authors include Nobuo Makino, Hideyo Sato, Shiro Bannai, Michiko Tamba, Satoru Takahashi, Ken-ichi Yagami, Takashi Moriguchi, Fumihiro Sugiyama, Nobuhiro Yamada and Hirohito Sone. Their work appears in journals such as Journal of Biological Chemistry, Brain Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026